Mangoceuticals (MGRX) Other Accumulated Expenses (2024 - 2026)

Mangoceuticals has disclosed Other Accumulated Expenses across 3 years of filings, most recently posting $147451.0 for Q2 2026.

• In Q2 2026, Other Accumulated Expenses fell 8.24% year-over-year to $147451.0; the TTM figure through Jun 2026 stood at $147451.0 (down 8.24% YoY), while the FY2025 annual figure was $156642.0, down 58.0% from the prior year.
• Other Accumulated Expenses came in at $147451.0 for Q2 2026 at Mangoceuticals, roughly flat from $147451.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $400000.0 in Q2 2024 to a low of $147451.0 in Q1 2026.
• Average Other Accumulated Expenses over 3 years is $241370.7, with a median of $160684.0 recorded in 2025.
• Year-over-year, Other Accumulated Expenses sank 59.83% in 2025 and fell 8.24% in 2026.
• Over 3 years, Other Accumulated Expenses stood at $373000.0 in 2024, then plunged by 58.0% to $156642.0 in 2025, then fell by 5.87% to $147451.0 in 2026.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $147451.0 in Q2 2026, $147451.0 in Q1 2026, and $156642.0 in Q4 2025.